340 related articles for article (PubMed ID: 28330785)
1. The interplay between Angiotensin II, TLR4 and hypertension.
Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
[TBL] [Abstract][Full Text] [Related]
2. Immune mechanisms in angiotensin II-induced target-organ damage.
Luft FC; Dechend R; Müller DN
Ann Med; 2012 Jun; 44 Suppl 1():S49-54. PubMed ID: 22713149
[TBL] [Abstract][Full Text] [Related]
3. [The role of the immune system in the pathogenesis of hypertension].
Leibowitz A; Grossman E
Harefuah; 2014 Jan; 153(1):17-8, 65. PubMed ID: 24605401
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, immunity, and hypertensive end-organ damage.
McMaster WG; Kirabo A; Madhur MS; Harrison DG
Circ Res; 2015 Mar; 116(6):1022-33. PubMed ID: 25767287
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Immunity and Hypertension.
Lopez Gelston CA; Mitchell BM
Am J Hypertens; 2017 Jul; 30(7):643-652. PubMed ID: 28200062
[TBL] [Abstract][Full Text] [Related]
6. Are the innate and adaptive immune systems setting hypertension on fire?
Bomfim GF; Rodrigues FL; Carneiro FS
Pharmacol Res; 2017 Mar; 117():377-393. PubMed ID: 28093357
[TBL] [Abstract][Full Text] [Related]
7. The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy.
Feng Q; Liu D; Lu Y; Liu Z
J Immunol Res; 2020; 2020():6193407. PubMed ID: 32411800
[TBL] [Abstract][Full Text] [Related]
8. A role for innate immunity in the development of hypertension.
Gomolak JR; Didion SP
Med Hypotheses; 2014 Dec; 83(6):640-3. PubMed ID: 25441337
[TBL] [Abstract][Full Text] [Related]
9. Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II-Induced Hypertension.
Xiao L; Kirabo A; Wu J; Saleh MA; Zhu L; Wang F; Takahashi T; Loperena R; Foss JD; Mernaugh RL; Chen W; Roberts J; Osborn JW; Itani HA; Harrison DG
Circ Res; 2015 Aug; 117(6):547-57. PubMed ID: 26156232
[TBL] [Abstract][Full Text] [Related]
10. The central nervous system and inflammation in hypertension.
Marvar PJ; Lob H; Vinh A; Zarreen F; Harrison DG
Curr Opin Pharmacol; 2011 Apr; 11(2):156-61. PubMed ID: 21196131
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 4 inhibition reduces vascular inflammation in spontaneously hypertensive rats.
Bomfim GF; Echem C; Martins CB; Costa TJ; Sartoretto SM; Dos Santos RA; Oliveira MA; Akamine EH; Fortes ZB; Tostes RC; Webb RC; Carvalho MH
Life Sci; 2015 Feb; 122():1-7. PubMed ID: 25498891
[TBL] [Abstract][Full Text] [Related]
12. The immune system in hypertension.
Trott DW; Harrison DG
Adv Physiol Educ; 2014 Mar; 38(1):20-4. PubMed ID: 24585465
[TBL] [Abstract][Full Text] [Related]
13. The immunological basis of hypertension.
Rodríguez-Iturbe B; Pons H; Quiroz Y; Johnson RJ
Am J Hypertens; 2014 Nov; 27(11):1327-37. PubMed ID: 25150828
[TBL] [Abstract][Full Text] [Related]
14. The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway.
Del Pinto R; Ferri C
High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):539-546. PubMed ID: 33047250
[TBL] [Abstract][Full Text] [Related]
15. Immune mechanisms in hypertension.
Leibowitz A; Schiffrin EL
Curr Hypertens Rep; 2011 Dec; 13(6):465-72. PubMed ID: 21842150
[TBL] [Abstract][Full Text] [Related]
16. The immune system in hypertension.
Harrison DG
Trans Am Clin Climatol Assoc; 2014; 125():130-38; discussion 138-40. PubMed ID: 25125726
[TBL] [Abstract][Full Text] [Related]
17. Immune mechanisms in hypertension and vascular injury.
Schiffrin EL
Clin Sci (Lond); 2014 Feb; 126(4):267-74. PubMed ID: 24144355
[TBL] [Abstract][Full Text] [Related]
18. Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension.
Sollinger D; Eißler R; Lorenz S; Strand S; Chmielewski S; Aoqui C; Schmaderer C; Bluyssen H; Zicha J; Witzke O; Scherer E; Lutz J; Heemann U; Baumann M
Cardiovasc Res; 2014 Mar; 101(3):464-72. PubMed ID: 24302630
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 4 (TLR4) impairs nitric oxide contributing to Angiotensin II-induced cavernosal dysfunction.
Nunes KP; Bomfim GF; Toque HA; Szasz T; Clinton Webb R
Life Sci; 2017 Dec; 191():219-226. PubMed ID: 29032115
[TBL] [Abstract][Full Text] [Related]
20. Adaptive Immunity in Hypertension.
Mikolajczyk TP; Guzik TJ
Curr Hypertens Rep; 2019 Jul; 21(9):68. PubMed ID: 31321561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
